iPSCs Cause Tumor Growth in the Heart
Author Information
Author(s): Zhang Yuzhen, Wang Dan, Chen Minglong, Yang Bing, Zhang Fengxiang, Cao Kejiang
Primary Institution: The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Hypothesis
Are undifferentiated induced pluripotent stem cells (iPSCs) tumorigenic after transplantation into the heart of immunocompetent rats?
Conclusion
The study shows that allogeneic iPSC transplantation in the heart can lead to tumor formation, highlighting safety concerns for future iPSC therapies.
Supporting Evidence
- 19 out of 98 rats developed tumors after receiving iPSC transplants.
- Tumor incidence was independent of the cell dose and transplant duration.
- Intracardiac tumors were more common than extracardiac tumors.
Takeaway
When scientists put special cells called iPSCs into the hearts of rats, they found that these cells could make tumors, which is a big worry for using them in medicine.
Methodology
The study involved transplanting different doses of rat iPSCs into the hearts of rats and examining them for tumor formation over various durations.
Potential Biases
Potential bias may arise from the use of allogeneic cells and the immune response of the recipient rats.
Limitations
The study did not explore the long-term effects of iPSC transplantation beyond the observed time points.
Participant Demographics
151 female Sprague-Dawley rats aged 6-10 weeks.
Statistical Information
P-Value
0.001
Statistical Significance
p=0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website